Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.5720
+0.0060 (1.06%)
At close: Aug 13, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 14.83 million as of August 13, 2026. Its market cap has decreased by -22.24% in one year.
Market Cap
14.83M
Enterprise Value
13.49M
Revenue
2.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
ChartMarket Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 14.83M, a decrease of -70.97%. That is a compound annual growth rate of -10.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 14.83M | -38.23% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 75.77M |
| Pila Pharma AB | 59.16M |
| Disruptive Pharma AB | 57.61M |
| 2cureX AB | 51.68M |
| Modus Therapeutics Holding AB | 46.83M |
| Fluicell AB | 41.62M |
| ExpreS2ion Biotech Holding AB | 36.22M |
| Alligator Bioscience AB | 23.62M |